• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Colin J Mooney, Govardhanan Nagaiah, +12 authors Scot C. Remick
  • Medicine
  • Thyroid : official journal of the American…
  • 2009 (First Publication: 1 March 2009)
  • BACKGROUND Fosbretabulin is a novel vascular-disrupting agent that has antitumor activity against anaplastic thyroid cancer (ATC) cell lines, xenografts, and demonstrable efficacy in a phase I trial.Continue Reading
  • Joseph Baar, Paula Silverman, +15 authors Beth A Overmoyer
  • Medicine
  • Clinical Cancer Research
  • 2009 (First Publication: 15 May 2009)
  • Purpose: Taxanes have effects on angiogenesis causing difficulties in separating biological effects of chemotherapy from those due to angiogenesis inhibitors. This randomized phase II trial wasContinue Reading
  • David E Weber, Maroun T. Semaan, Jay K. Wasman, Richard M. Beane, Lawrence J. Bonassar, Cliff A. Megerian
  • Medicine
  • The Laryngoscope
  • 2006 (First Publication: 1 May 2006)
  • OBJECTIVE Chronic tympanic membrane perforations are a common problem in the United States. A high number of these cases results from placement of pressure equalization tubes. These perforations mayContinue Reading
  • Rosemary Farag, James A. Schulak, Fadi W. Abdul-Karim, Jay K. Wasman
  • Medicine
  • Clinical nephrology
  • 2005 (First Publication: 1 May 2005)
  • Angiosarcoma in the setting of immunosuppressed renal transplant recipients is exceedingly rare. In this report, we describe the occurrence of angiosarcoma arising at an arteriovenous fistula site ofContinue Reading
  • Govardhanan Nagaiah, Pingfu Fu, +7 authors Scot C. Remick
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2009 (First Publication: 22 September 2016)
  • 6058 Background: Sorafenib (bay 43-9006) is an oral, small molecule tyrosine kinase inhibitor of the raf-1 protein kinase receptor, VEGFR2 and PDGFR-β with antiangiogenic properties. We areContinue Reading
  • Maroun T. Semaan, David A Gilpin, Daniel Pierce Hsu, Jay K. Wasman, Cliff A. Megerian
  • Medicine
  • The Laryngoscope
  • 2011 (First Publication: 1 August 2011)
  • OBJECTIVE To review the clinical presentation, surgical techniques, and outcomes of the transmastoid extradural-intracranial (TMEDIC) approach for the treatment of transtemporal meningoencephalocele.Continue Reading
  • Beth A Overmoyer, Pingfu Fu, +17 authors Scot C. Remick
  • Medicine
  • Clinical Cancer Research
  • 2007 (First Publication: 1 October 2007)
  • Purpose: We used inflammatory breast cancer (IBC) as a model disease to investigate biological changes associated with an antiangiogenesis agent, SU5416, combined with doxorubicin. ExperimentalContinue Reading